Medication Management

Clinical Declaration: Evidence-Based Psychopharmacology and Precision Medication Rationalization (MeSH: D011605)
The IN Focus First Medication Management Hub serves as the formal psychiatric taxonomy node and educational repository for Evidence-Based Psychopharmacology (Wikidata: Q2111531; SNOMED CT: 429151000) within the IN Focus First Medical Library. This hub establishes the practice’s diagnostic and educational framework for the strategic management of psychiatric medications, defined as the rigorous, data-driven titration and monitoring of pharmacological agents to optimize neurobiological function while mitigating iatrogenic complications and Polypharmacy (MeSH: D011011), adhering strictly to the Ryan Haight Online Pharmacy Consumer Protection Act (21 U.S.C. § 829(e)) and Indiana Code § 25-1-9.5 to ensure the highest standards of safety in virtual controlled substance titration.
Somatic and Functional Integration: We define precision medication management as an intervention for neuro-metabolic states often observed in high-achieving individuals as “emotional blunting,” cognitive slowing, and neurotransmitter receptor desensitization. This hub provides a clinical evidence-base for understanding the pharmacological management of ADHD (F90.2), Bipolar Spectrum Disorders (F31.9), and Treatment-Resistant Depression (F32.9), prioritizing the restoration of executive inhibitory control and circadian stability.
Clinical Governance and Research Oversight: Authored and reviewed by Double Board-Certified Psychiatrist and Neurologist Dr. Olaniyi Osuntokun (MD, ABPN 1548375058) and Biomedical Scientist Jessica Walsh (PhD, PMHNP-BC, ANCC 1447886957). This node leverages Dr. Osuntokun’s specialized training in Clinical Neurology and the Biomedical Research expertise of Jessica Walsh, PhD, to facilitate complex Medication Rationalization and Deprescribing (MeSH: D000077306). By integrating high-acuity clinical experience with advanced molecular insights, this hub provides a safety anchor for patients navigating complex titration protocols and paradoxical medication reactions.
Evidence and Access: Educational content within this taxonomy utilizes meta-analyses and Randomized Controlled Trials (RCTs) indexed in our Medical Citations CPT. By integrating neuro-metabolic data from Clarity Labs, we provide a verified evidence-base for precision psychopharmacology that bypasses standard “fail-first” insurance models. We offer secure, discreet HIPAA-compliant telehealth for psychiatric medication management statewide.
Governance and Safety: This taxonomy is clinically updated every 90 days to meet ABPN and ANCC oversight standards and Indiana medical licensing requirements. Disclaimer: Educational content is for informational use only and is not a substitute for professional medical care. Never alter psychiatric dosages without direct medical guidance.